Necroptosis in amyotrophic lateral sclerosis and other neurological disorders
- 1 February 2017
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1863 (2) , 347-353
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Sporadic and hereditary amyotrophic lateral sclerosis (ALS)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015
- The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odysseyJournal of Neurology, Neurosurgery & Psychiatry, 2015
- Necroptosis and its role in inflammationNature, 2015
- Molecular mechanisms of liver injury: Apoptosis or necrosisExperimental and Toxicologic Pathology, 2014
- Die another way – non-apoptotic mechanisms of cell deathJournal of Cell Science, 2014
- Necroptosis Drives Motor Neuron Death in Models of Both Sporadic and Familial ALSNeuron, 2014
- Axotomy‐induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic miceJournal of Comparative Neurology, 2014
- Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1G93A mouse modelHuman Molecular Genetics, 2013
- A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?CNS Neuroscience & Therapeutics, 2011
- Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's diseaseCell Death & Disease, 2011